Tradestie Institutional Equity Comparison Engine
EW vs SYK โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SYK Overall Edge
SYK Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Valuation, Options & Structure while EW counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus SYK at 19.0x Forward P/E and 24.0% operating margin (+7.6% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SYK
EW 31.6x vs SYK 19.0x Fwd P/E
Growth & Margin Winner
EW
Op Margin 28.8% vs 24.0% ยท YoY +10.5% vs +7.6%
Momentum & Technical Winner
EW
1Y +23.9% vs -16.8% ยท 52W Pos 96% vs 36%
Options & Structure Winner
SYK
UNCLASSIFIED (34th %ile IV) vs SURGE (5th %ile IV)
EW
NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap
$60.8B
1M Return
+23.16%
1Y Return
+23.86%
Forward P/E
31.6x
Unified AI Score
31.5 / 100
SELL
Tech 50.0
Fund 29.0
Flow 51.0
Mom 44.0
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EW +23.86%
SYK -16.77%
Spread: +40.63 pp (EW Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | EW Revenue | SYK Revenue | EW Op. Margin | SYK Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $3.72B | $13.6B | 20.1% | 18.7% | EW |
| FY2019 | $4.35B | $14.9B | 26.4% | 18.2% | EW |
| FY2020 | $4.39B | $14.3B | 20.5% | 15.5% | EW |
| FY2021 | $5.23B | $17.1B | 32.3% | 15.1% | EW |
| FY2022 | $4.46B | $18.4B | 33.6% | 15.4% | EW |
| FY2023 | $5.01B | $20.5B | 26.1% | 19.0% | EW |
| FY2024 | $5.44B | $22.6B | 25.3% | 16.3% | EW |
| FY2025 | $6.07B | $25.1B | 20.8% | 19.5% | EW |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EW | SYK | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $60.8B | $118.9B | Larger Scale | SYK |
| Trailing P/E Ratio Valuation | 61.5x | 33.3x | Lower Multiple | SYK |
| Forward P/E Ratio Valuation | 31.6x | 19.0x | Lower Multiple | SYK |
| Revenue Growth (YoY) Growth | +10.5% | +7.6% | Higher Growth | EW |
| Operating Margin (TTM) Profitability | 28.8% | 24.0% | Higher Margin | EW |
| Net Profit Margin Profitability | 15.3% | 13.8% | Higher Margin | EW |
| Return on Equity (ROE) Capital Efficiency | 9.3% | 16.0% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 96% ($75โ$108) | 36% ($267โ$389) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | 0.44ฮฒ ยท 24% Vol | 0.22ฮฒ ยท 50% Vol | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 31.5 / 100 (SELL) | 46.5 / 100 (HOLD) | Higher Composite | SYK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EW vs SYK Buy Guide
EW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EW nor SYK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.